Roel Willemze
About
Roel Willemze is a scholar working on Hematology, Immunology and Oncology.
According to data from OpenAlex, Roel Willemze has authored 288 papers receiving a total of 14.3k indexed citations (citations by other indexed papers that have themselves been cited), including 162 papers in Hematology, 135 papers in Immunology and 67 papers in Oncology. Recurrent topics in Roel Willemze's work include Hematopoietic Stem Cell Transplantation (111 papers), Acute Myeloid Leukemia Research (75 papers) and Immune Cell Function and Interaction (69 papers). Roel Willemze is often cited by papers focused on Hematopoietic Stem Cell Transplantation (111 papers), Acute Myeloid Leukemia Research (75 papers) and Immune Cell Function and Interaction (69 papers). Roel Willemze collaborates with scholars based in Netherlands, Italy and Belgium. Roel Willemze's co-authors include Willem E. Fibbe, J.H. Frederik Falkenburg, Alwine B. Kruisselbrink, Ellie G.A. Lurvink, Hanneke C. Kluin‐Nelemans, JH Falkenburg, Mirjam H.M. Heemskerk, Alma J. Nauta, Michel G.D. Kester and Renée M. Y. Barge and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.
In The Last Decade
Roel Willemze
283 papers receiving 14.0k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Roel Willemze Netherlands | 59 | 7.3k | 5.4k | 3.9k | 3.4k | 3.3k | 288 | 14.3k | ||
| Maria Paola Martelli Italy | 64 | 10.4k 1.4× | 8.2k 1.5× | 4.5k 1.2× | 4.3k 1.3× | 2.5k 0.8× | 354 | 18.6k | ||
| Francesco Frassoni Italy | 60 | 9.7k 1.3× | 5.5k 1.0× | 4.0k 1.0× | 2.9k 0.8× | 7.3k 2.2× | 327 | 18.5k | ||
| Todd E. DeFor United States | 62 | 10.1k 1.4× | 6.5k 1.2× | 5.1k 1.3× | 1.7k 0.5× | 2.9k 0.9× | 297 | 15.7k | ||
| Gale Rp United States | 48 | 8.5k 1.2× | 3.2k 0.6× | 2.8k 0.7× | 1.6k 0.5× | 2.2k 0.7× | 173 | 11.1k | ||
| Jürgen Finke Germany | 58 | 6.9k 0.9× | 3.4k 0.6× | 3.8k 1.0× | 1.8k 0.5× | 2.7k 0.8× | 396 | 12.9k | ||
| Mitchell S. Cairo United States | 61 | 4.8k 0.7× | 3.0k 0.6× | 4.5k 1.2× | 2.7k 0.8× | 2.6k 0.8× | 507 | 14.9k | ||
| Attilio Orazi United States | 49 | 8.8k 1.2× | 2.4k 0.4× | 2.8k 0.7× | 4.5k 1.3× | 6.8k 2.1× | 281 | 16.1k | ||
| Daniel C. Link United States | 62 | 4.9k 0.7× | 5.4k 1.0× | 3.1k 0.8× | 4.2k 1.2× | 2.5k 0.8× | 209 | 13.3k | ||
| C. Ellen van der Schoot Netherlands | 57 | 5.9k 0.8× | 2.4k 0.5× | 1.4k 0.3× | 2.8k 0.8× | 2.0k 0.6× | 332 | 11.5k | ||
| Ephraim J. Fuchs United States | 52 | 5.7k 0.8× | 4.7k 0.9× | 2.9k 0.7× | 1.6k 0.5× | 1.4k 0.4× | 191 | 9.8k |
Countries citing papers authored by Roel Willemze
Since
Specialization
Citations
This map shows the geographic impact of Roel Willemze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roel Willemze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roel Willemze more than expected).
Fields of papers citing papers by Roel Willemze
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Roel Willemze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roel Willemze. The network helps show where Roel Willemze may publish in the future.
Co-authorship network of co-authors of Roel Willemze
This figure shows the co-authorship network connecting the top 25 collaborators of Roel Willemze. A scholar is included among the top collaborators of Roel Willemze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roel Willemze. Roel Willemze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Bergen, Cornelis A.M. van, Caroline E. Rutten, Edith D. van der Meijden, et al.. (2010). High-Throughput Characterization of 10 New Minor Histocompatibility Antigens by Whole Genome Association Scanning. Cancer Research. 70(22). 9073–9083.
2.
Veken, Lars T. van der, María Díez‐Campelo, Menno A. W. G. van der Hoorn, et al.. (2009). Functional Analysis of Killer Ig-Like Receptor-Expressing Cytomegalovirus-Specific CD8+ T Cells. The Journal of Immunology. 182(1). 92–101.
3.
Bergen, Cornelis A.M. van, Michel G.D. Kester, Inge Jedema, et al.. (2007). Multiple myeloma–reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene. Blood. 109(9). 4089–4096.
4.
Nauta, Alma J., Geert Westerhuis, Alwine B. Kruisselbrink, et al.. (2006). Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood. 108(6). 2114–2120.
5.
Nauta, Alma J., Alwine B. Kruisselbrink, Ellie G.A. Lurvink, Roel Willemze, & Willem E. Fibbe. (2006). Mesenchymal Stem Cells Inhibit Generation and Function of Both CD34+-Derived and Monocyte-Derived Dendritic Cells. The Journal of Immunology. 177(4). 2080–2087.
6.
Amadori, Sergio, Stefan Suciu, Roberto Stasi, et al.. (2005). Gemtuzumab ozogamicin (Mylotarg®) as single-agent treatment for frail patients 61 years of age and older with acute myeloid leukemia: final results of AML-15B, a phase 2 study of the European Organisation for Research and Treatment of Cancer and Gruppo Italiano Malattie Ematologiche dell'Adulto Leukemia Groups. Leukemia. 19(10). 1768–1773.
7.
Hoogendoorn, Mels, W. M. Smit, Martyn Ronald Schaafsma, et al.. (2004). Generation of B-cell chronic lymphocytic leukemia (B-CLL)-reactive T-cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapy. Leukemia. 18(7). 1278–1287.
8.
Velders, Gerjo A., Ronald van Os, H. F. L. Guiot, et al.. (2003). Reduced stem cell mobilization in mice receiving antibiotic modulation of the intestinal flora: involvement of endotoxins as cofactors in mobilization. Blood. 103(1). 340–346.
9.
Suciu, Stefan, T de Witte, Franco Mandelli, et al.. (2002). Allogeneic vs autologous stem cell transplantation according to cytogenetic and FAB features in AML patients (pts) <=45 yrs old in CRI: Results of the EORTC-GIMEMA AML-10 trial. Bone Marrow Transplantation. 29.
10.
Groot, Carin A. Uyl‐de, et al.. (2001). Costs of Diagnosis, Treatment, and Follow Up of Patients with Acute Myeloid Leukemia in the Netherlands. Journal of Hematotherapy & Stem Cell Research. 10(1). 187–192.
11.
Suciu, Stefan, R Zittoun, Franco Mandelli, et al.. (2001). Allogeneic vs autologous stem cell transplantation according to cytogenetic features in AML patients (pts) <= 45 yrs old in first CR: Results of the EORTC-GIMEMA AML-10 trial. Blood. 98(11).
12.
Witte, T. de, R Zittoun, L Resegotti, et al.. (2000). The type of anthracycline administered during remission induction and consolidation therapy of AML has an impact on feasibility of subsequent autologous or allogeneic transplantation and induced marrow toxicity: preliminary results of the EORTC-Gimema AML-10 randomized trial.. Blood. 96(11).
13.
Pruijt, Hans, Yvette van Kooyk, Carl G. Figdor, Roel Willemze, & Willem E. Fibbe. (1999). Murine Hematopoietic Progenitor Cells With Colony-Forming or Radioprotective Capacity Lack Expression of the β2-Integrin LFA-1. Blood. 93(1). 107–112.
14.
Croockewit, Alexandra, Miguel H. Bronchud, Matti Aapro, et al.. (1997). A European perspective on haematopoietic growth factors in haemato-oncology: Report of an expert meeting of the EORTC. European Journal of Cancer. 33(11). 1732–1746.
15.
Fibbe, Willem E., J. M. J. M. Zijlmans, & Roel Willemze. (1997). Differential short‐term and long‐term repopulating ability of stem cell subsets in mice. Stem Cells. 15(S2). 47–53.
16.
Goselink, Henriëtte M., Jo Van Damme, Pieter S. Hiemstra, et al.. (1996). Colony growth of human hematopoietic progenitor cells in the absence of serum is supported by a proteinase inhibitor identified as antileukoproteinase.. The Journal of Experimental Medicine. 184(4). 1305–1312.
17.
Zittoun, R, Stefan Suciu, G. Solbu, et al.. (1995). Comparison of quality of life (QOL) of patients with acute myelogenous leukemias (AML) in long-term first complete remission (CR) after bone marrow transplantation (BMT) - Allogeneic or autologous - Or intensive chemotherapy consolidation (ICC): EORTC-GIMEMA AML 8A study. Blood. 86(10). 1718–1718.
18.
Willemze, Roel, et al.. (1992). Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia.. The Journal of Experimental Medicine. 176(5). 1283–1289.
19.
Falkenburg, JH, JE Landegent, N Duinkerken, et al.. (1991). In vivo production of interleukin-5, granulocyte-macrophage colony- stimulating factor, macrophages colony-stimulating factor, and interleukin-6 during intravenous administration of high-dose interleukin-2 in cancer patients [see comments]. Blood. 78(8). 1981–1987.
20.
Willemze, Roel & Richard I. Walker. (1981). The in vivo diffusion chamber technique for bone marrow or blood cell culture. Annals of Hematology. 42(2). 59–67.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Maria Paola Martelli Breakdown of academic impact, for papers by Francesco Frassoni Breakdown of academic impact, for papers by Todd E. DeFor Breakdown of academic impact, for papers by Gale Rp Breakdown of academic impact, for papers by Jürgen Finke Breakdown of academic impact, for papers by Mitchell S. Cairo Breakdown of academic impact, for papers by Attilio Orazi Breakdown of academic impact, for papers by Daniel C. Link Breakdown of academic impact, for papers by C. Ellen van der Schoot Breakdown of academic impact, for papers by Ephraim J. Fuchs